{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:23:17Z","timestamp":1793139797027,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["PP 180091"],"award-info":[{"award-number":["PP 180091"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.cgh.2022.04.031","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T22:25:13Z","timestamp":1652480713000},"page":"988-994.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Patient Navigation Increases Linkage to Care and Receipt of Direct-acting Antiviral Therapy in Patients with Hepatitis C"],"prefix":"10.1016","volume":"21","author":[{"given":"Joslyn","family":"Strebe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole E.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit G.","family":"Singal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McBryde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Fullington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyaun L.","family":"Villarreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertha","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2292-6544","authenticated-orcid":false,"given":"Mamta K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2022.04.031_bib1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12916-017-0969-3","article-title":"Effectiveness of direct-acting antiviral therapy for hepatitis C in difficult-to-treat patients in a safety-net health system: a retrospective cohort study","volume":"15","author":"Yek","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/j.cgh.2022.04.031_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/jvh.13436","article-title":"Hepatitis C virus infection mortality trends according to three definitions with special concern for the baby boomer birth cohort","volume":"28","author":"Sheu","year":"2021","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cgh.2022.04.031_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13027-016-0076-7","article-title":"Systemic manifestations of hepatitis C infection","volume":"11","author":"Tang","year":"2016","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.cgh.2022.04.031_bib4","first-page":"139","article-title":"Hepatitis C virus infection, and neurological and psychiatric disorders - A review","volume":"8","author":"Yarlott","year":"2017","journal-title":"J\u00a0Adv Res"},{"key":"10.1016\/j.cgh.2022.04.031_bib5","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/jvh.12985","article-title":"Canadian Co-Infection Cohort Study Investigators. Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV\/Hepatitis C co-infected individuals","volume":"25","author":"Saeed","year":"2018","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cgh.2022.04.031_bib6","doi-asserted-by":"crossref","first-page":"1093.e5","DOI":"10.1016\/j.cmi.2020.04.029","article-title":"Patient-reported outcomes of sleep, mood and quality of life after treatment of chronic hepatitis C infection using direct-acting antiviral agents","volume":"26","author":"Karimi-Sari","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cgh.2022.04.031_bib7","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/jvh.13546","article-title":"Only partial improvement in health-related quality of life after treatment of chronic hepatitis C virus infection with direct acting antivirals in a real-world setting-results from the German Hepatitis C-Registry (DHC-R)","volume":"28","author":"Ohlendorf","year":"2021","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cgh.2022.04.031_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1053\/j.gastro.2018.04.008","article-title":"Rete Sicilia Selezione Terapia\u2013HCV (RESIST-HCV). Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents","volume":"155","author":"Calvaruso","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.04.031_bib9","first-page":"1","article-title":"Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965","volume":"61","author":"Smith","year":"2012","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.cgh.2022.04.031_bib10","article-title":"A\u00a0national strategy for the elimination of hepatitis B and C: phase two report","year":"2017"},{"key":"10.1016\/j.cgh.2022.04.031_bib11","first-page":"1","article-title":"Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention","volume":"47","year":"1998","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.cgh.2022.04.031_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.7326\/0003-4819-159-5-201309030-00672","article-title":"Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement","volume":"159","author":"Moyer","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2022.04.031_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/hep.30638","article-title":"Evaluation of a multifaceted intervention to reduce health disparities in hepatitis C screening: a pre-post analysis","volume":"70","author":"Jain","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.04.031_bib14","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/acem.13484","article-title":"Implementation and preliminary results of an emergency department nontargeted, opt-out hepatitis C virus screening program","volume":"25","author":"Schechter-Perkins","year":"2018","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.cgh.2022.04.031_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218388","article-title":"HCV screening, linkage to care, and treatment patterns at different sites across one academic medical center","volume":"14","author":"Calner","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2022.04.031_bib16","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/hep.29362","article-title":"Impact of an electronic health record alert in primary care on increasing hepatitis c screening and curative treatment for baby boomers","volume":"66","author":"Konerman","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.04.031_bib17","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/jvh.13278","article-title":"Patient and provider-level barriers to hepatitis C screening and linkage to care: a mixed-methods evaluation","volume":"27","author":"Higashi","year":"2020","journal-title":"J\u00a0Viral Hepatitis"},{"key":"10.1016\/j.cgh.2022.04.031_bib18","article-title":"Multi-center randomized clinical trial of a mailed outreach strategy for hepatocellular carcinoma surveillance","author":"Singal","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"15 Suppl","key":"10.1016\/j.cgh.2022.04.031_bib19","first-page":"3543","article-title":"The role of patient navigators in eliminating health disparities","volume":"117","author":"Natale-Pereira","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2022.04.031_bib20","first-page":"38","article-title":"Reaching for the cure: Texas Medicaid doesn't cover hepatitis C drugs until patients are seriously ill","volume":"116","author":"Price","year":"2020","journal-title":"Tex Med"},{"key":"10.1016\/j.cgh.2022.04.031_bib21","doi-asserted-by":"crossref","first-page":"ofab334","DOI":"10.1093\/ofid\/ofab334","article-title":"Care facilitation advances movement along the hepatitis C care continuum for persons with human immunodeficiency virus, hepatitis C, and substance use: a randomized clinical trial (CTN-0064)","volume":"8","author":"Metsch","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cgh.2022.04.031_bib22","first-page":"226","article-title":"Hepatitis C screening: barriers to linkage to care","volume":"7","author":"Saab","year":"2019","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.cgh.2022.04.031_bib23","first-page":"329","article-title":"Increasing access to hepatitis C virus medications: a program model using patient navigators and specialty pharmacy to obtain prior authorization approval","volume":"24","author":"Vu","year":"2018","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.cgh.2022.04.031_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2019.105859","article-title":"Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study","volume":"87","author":"Litwin","year":"2019","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.cgh.2022.04.031_bib25","doi-asserted-by":"crossref","first-page":"976","DOI":"10.14309\/ajg.0000000000001085","article-title":"Randomized clinical trial of inreach with or without mailed outreach to promote hepatitis C screening in a difficult-to-reach patient population","volume":"116","author":"Desai","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2022.04.031_bib26","first-page":"e257","article-title":"Evaluating HCV screening, linkage to care, and treatment across insurers","volume":"24","author":"Mulligan","year":"2018","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.cgh.2022.04.031_bib27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000501821","article-title":"Identifying barriers to the treatment of chronic hepatitis C infection","volume":"38","author":"Al-Khazraji","year":"2020","journal-title":"Dig Dis"},{"key":"10.1016\/j.cgh.2022.04.031_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2022.01.023","article-title":"HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: a meta-analysis","author":"Singal","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.04.031_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cgh.2020.09.036","article-title":"Conceptual model for the hepatocellular carcinoma screening continuum: current status and research agenda","volume":"20","author":"Singal","year":"2022","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235652200458X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235652200458X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:40:48Z","timestamp":1761543648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154235652200458X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S154235652200458X"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2022.04.031","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient Navigation Increases Linkage to Care and Receipt of Direct-acting Antiviral Therapy in Patients with Hepatitis C","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2022.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the AGA Institute. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}